AI could end antidepressant Trial-and-Error for depression
NCT ID NCT06550037
Summary
This study aims to create a tool to help doctors choose the right antidepressant for each patient with major depression. Researchers will collect blood, stool, and saliva samples, along with brainwave data and mood tracking from 350 participants over two years. They will use artificial intelligence to analyze all this information and find patterns that predict which treatments work best for different people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Università Degli Studi Di Siena
Siena, 53100, Italy
Conditions
Explore the condition pages connected to this study.